XT
INMB icon

XTX Topco’s INmune Bio INMB Stock Holding History

XTX Topco’s Portfolio INMB Stock Details INMB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$34.2K Sell
30,306
-38,559
-56% -$54.9K ﹤0.01% 3419
2025
Q4 		$107K Buy
68,865
+20,121
+41% +$35.9K ﹤0.01% 2618
2025
Q3 		$101K Sell
48,744
-77,103
-61% -$176K 0.01% 2022
2025
Q2 		$291K Buy
125,847
+88,928
+241% +$653K 0.01% 1457
2025
Q1 		$288K Sell
36,919
-24,352
-40% -$193K 0.01% 1439
2024
Q4 		$286K Buy
61,271
+15,018
+32% +$78.3K 0.02% 1262
2024
Q3 		$249K Buy
+46,253
New +$329K 0.02% 1312

Other funds holding INMB

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

XTX Topco's INMB Position: Q1 2026 in Review

XTX Topco reduced its INmune Bio (INMB) stake by 56% in Q1 2026, selling an estimated $54.9K and leaving 30,306 shares worth $34.2K. The position accounts for ﹤0.01% of the portfolio, ranked #3419.

XTX Topco first reported a position in INMB in Q3 2024 and has held it in 7 quarters since. The position peaked at $291K in Q2 2025. 82 funds tracked by Wall St. Rank hold INMB as of Q1 2026.

  • XTX Topco held 30,306 shares of INmune Bio worth $34.2K as of Q1 2026.
  • XTX Topco sold 38,559 INmune Bio shares in Q1 2026, an estimated $54.9K.
  • INmune Bio made up ﹤0.01% of XTX Topco's portfolio in Q1 2026, its #3419 holding.
  • XTX Topco first reported a position in INmune Bio in Q3 2024 and has held it in 7 quarters since.
  • XTX Topco's INmune Bio position peaked at $291K in Q2 2025.
  • 82 funds tracked by Wall St. Rank held INmune Bio as of Q1 2026.

Based on XTX Topco's 13F filing for Q1 2026, filed 15 May 2026.